Literature DB >> 628387

Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation.

A D Toft, W J Irvine, I Sinclair, D McIntosh, J Seth, E H Cameron.   

Abstract

We assessed thyroid function for 12 months after subtotal thyroidectomy in 100 tyrotoxic patients treated with propranolol alone before and immediately after operation. The operation proved safe, with low morbidity. Suppression of the hypothalamic-pituitary-thyroid axis, present in the majority one month after operation, was evidenced by normal or low levels of serum total tri-iodothyronine and thyroxine, but absent or subnormal serum thyrotropin response to thyrotropin-releasing hormone. Eighty patients were euthyroid at 12 months. Three patterns of thyroid function were observed in this group between the first and 12th months: normal serum total tri-iodothyronine, thyroxine and thyrotropin levels at all stages (20 patients); normal serum total tri-iodothyronine and thyroxine, but raised thyrotropin levels on one or more occasions (40 patients); and temporary hypothyroidism (20 patients). Of the remaining 20 patients, permanent hypothyroidism developed in 14, and six relapsed. Postoperative thyroid function was related to the estimated weight of the thyroid remnant.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628387     DOI: 10.1056/NEJM197803232981202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

1.  Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.

Authors:  Y Mori; N Matoba; S Miura; N Sakai; Y Taira
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

2.  Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol.

Authors:  J F Haddad; S Tibblin
Journal:  Ann R Coll Surg Engl       Date:  1988-11       Impact factor: 1.891

Review 3.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

4.  Thyroid surgery for Graves' disease.

Authors:  A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-05

5.  Lithium carbonate in the preoperative preparation of Graves' disease.

Authors:  T Tsunoda; N Mochinaga; T Eto; M Yamaguchi; R Tsuchiya; M Izumi
Journal:  Jpn J Surg       Date:  1991-05

6.  A sensitive immunoradiometric assay for serum thyroid stimulating hormone: a replacement for the thyrotrophin releasing hormone test?

Authors:  J Seth; H A Kellett; G Caldwell; V M Sweeting; G J Beckett; S M Gow; A D Toft
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

Review 7.  Subclinical hypothyroidism. To treat or not to treat.

Authors:  E A Laryea
Journal:  Can Fam Physician       Date:  1993-09       Impact factor: 3.275

8.  Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.

Authors:  K Sugino; T Mimura; K Toshima; H Iwabuchi; Y Kitamura; M Kawano; O Ozaki; K Ito
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

Review 9.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

10.  [Hyperthyroidism (author's transl)].

Authors:  H Studer
Journal:  Langenbecks Arch Chir       Date:  1978-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.